✦ LIBER ✦
Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome
✍ Scribed by Larry D. Lynd; Mehdi Najafzadeh; Lindsey Colley; Michael F. Byrne; Andrew R. Willan; Mark J. Sculpher; F. Reed Johnson; A. Brett Hauber
- Book ID
- 109079048
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 246 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.